Latest news
LTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort - smallcaps.com.ausmallcaps.com.au · Tue, 11 Aug 2026 04:07:30 GMTDaily Special: Iltani Resources, Nanoveu, LTR Pharma, Mont Royal Resources, Lithium Universe - SharecafeSharecafe · Tue, 11 Aug 2026 03:17:50 GMTHealth Check: The hard evidence suggests LTR Pharma’s ED drug is quick and effective - StockheadStockhead · Tue, 11 Aug 2026 02:37:18 GMTMorning Feed: What’s cooking on the ASX? - StockheadStockhead · Tue, 11 Aug 2026 00:39:52 GMTLTR Pharma (ASX:LTP) posts 93% response in 147-patient SPONTAN study as US launch nears - Stocks Down UnderStocks Down Under · Tue, 11 Aug 2026 00:16:18 GMTLTR Pharma Reports 93% Response Rate in 147-Patient SPONTAN® Real-World Study - KalkineKalkine · Mon, 10 Aug 2026 23:15:02 GMT# What is the new nasal spray for erectile dysfunction - View nGwbaRDJo - Magiczny KrakówMagiczny Kraków · Sun, 02 Aug 2026 18:57:11 GMTLTR Pharma Advances Intranasal Pipeline with Key Clinical Data and U.S. Commercial Partnerships Ahead of ROXUS Launch - Kalkine MediaKalkine Media · Tue, 28 Jul 2026 07:00:00 GMT